The phrase 'translational research' 
Introduction
The myofibroblast is known primarily for its role in wound healing [1, 2] , and in this capacity it promotes the health of the mammalian organism. The myofibroblast persists in abnormal wound healing and is also present in other clinically and histopathologically distinct fibroproliferative conditions [3] [4] [5] [6] [7] . In addition, it can be present in large numbers in tumour stroma, particularly of epithelial cancers [3] [4] [5] [6] [7] , and in this respect, it has a negative impact on health by promoting tumour progression. We now have a great deal of detailed information from experimental and diagnostic pathologists on the processes in which myofibroblasts participate in fibroses and in the promotion of cancer -indeed, the cell is now being mentioned as a target for therapeutic intervention in translational medicine [8, 9] .
And yet, there is a great deal of evidence from the literature indicating a failure to understand the cellular differentiation of the myofibroblast. This is partly because the initial definition was largely based on electron microscopy, and in recent years this technique has been somewhat neglected by experimentalists and cancer cell biologists: to a significant degree, it has been displaced by other techniques, such as immunohistochemistry, confocal microscopy and molecular biological procedures. This paper promotes a precise definition of the myofibroblast in order to promote a better understanding of the nature of this cell in its role as a major player in translational medicine in fibrotic conditions, cancer and tissue engineering. The review also illustrates how a precise definition, emphasising cellular structure, can inform normal cell biology and pathology thinking.
The evolving definition of the myofibroblast: promoting an understanding of biology and pathology Table 1 .
From early ultrastructural criteria to a comprehensive definition

A comprehensive definition of the myofibroblast has been promoted in recent years [10-15], which includes light microscopy features as seen in haematoxylin and eosin sections, immunophenotype and ultrastructure. The definition of the fully differentiated myofibroblast is given in
It has taken more than three decades for this definition to evolve since the first use of the term myofibroblast in the early 1970s. The term was introduced by Majno et al. [2] for the cells found in experimental wound-healing which had also been described by the same group as 'modified fibroblasts' [1] . These [5, 6, 32] Fig. 2A) , but there are several significant differences ( Fig. 2A and B [5, 25, 40] either conform to the imprecise immunohistochemical definition (SMA positivity in a spindled cell) [57] , or lack the full complement of ultrastructural features as outlined above for the myofibroblast (Table 1) : in particular, they invariably lack fibronexus junctions and some possess unambiguous lamina (e.g., [58] [59] [60] [61] [62] [63] [64] [65] . Periodontal ligaments are indeed subjected to the continual stress of tooth movement during mastication [66] [67] , while the testicular lamina propria is also regarded as a dynamic tissue, where myofibroblasts with cell-to-matrix devices very similar to modestly developed fibronexuses have been described [68] .
No one would deny that the stark classification of stromal cells into fibroblasts and smooth-muscle cells as in Fig. 3 is a simplification and should be used as a guide (see [69] [90] . [91] [92] [93] . It is not surprising, therefore, that fibronectin has been found to influence the migration of tumour cells [94, 95] . Moreover, EDA fibronectin is known to activate matrix metalloproteinase production [96] [97] . Increasingly, however, attention is being focussed on to two other mechanisms -derivation from bone-marrow-derived circulating fibrocytes and origin from epithelial-mesenchymal transformation. [98] [99] , granulation tissue [21, 100, 101] , fibrosing conditions [102, 103] and tumour stroma [56, 104, 105] (see Quan et al. [106] [107] , other data suggest that smooth-muscle cells healing atherosclerotic plaques are from local tissue origin [108] .
• Myofibroblasts are often found in the tumourstroma interface, and may form a barrier between tumour cells and host immune cells, thereby interfering with the host's ability to mount an immune defence against cancer [23, 55]. De Wewer and Mareel [55] have emphasized the need for a detailed understanding of myofibroblastic activity and in particular the biochemical communication between myofibroblasts and tumour cells as a pre-requisite for the development of therapeutic applications. Many of the studies that have led to our current understanding of these complex processes have lacked an ultrastructural input: so, is there a role for the ultrastructurally-enhanced definition of the myofibroblast -a key player -in such studies? The ultrastructural definition of the myofibroblast tells us that in particular this cell has what we might think of as a very physical involvement with its extracellular space, through the fibronexus and its fibrillar fibronectin. This is a feature which does not attract much attention in experimental cancer cell biology studies. And yet the surface of any cell is of paramount importance in its dealings with the outside world. What are the possible roles of the cell-surface fibronectin of these myofibroblasts? It has been known for a long time that fibronectin promotes a variety of cellular functions (cell attachment, differentiation, proliferation and migration) and acts as a 'migratory substrate' for embryonic cells
Bone-marrow-derived circulating fibrocytes, epithelial-mesenchymal transformation and the origin of myofibroblasts
Quite apart from the activity of myofibroblasts once located within granulation tissue, a focus of fibrosis or a tumour site, their origin is also inextricably bound up with the development of therapeutic intervention for these diseases. The traditional view has been that myofibroblasts arise from quiescent resident mesenchymal cells in the surrounding tissues -fibroblasts being the mainly implicated progenitor, but also pericytes, smooth-muscle cells and even endothelium
Bone-marrow-derived circulating cells (sometimes referred to as 'fibrocytes') have been demonstrated recently with the ability to localize to and populate tissue sites. These include normal tissues
Epithelial-mesenchymal transition or transformation (EMT) is the second major mechanism postulated to provide an origin for myofibroblasts in fibrosing conditions [109] and tumour stroma [82, 110] 
that is, 'ambiguous myofibroblasts') to fully differentiated myofibroblasts which would be SMA-positive fibronexus-bearing cells. One of the undoubted qualities of electron microscopy is that it can indeed provide information on a level of differentiation. In this respect, the reference to 'complete transition to … mesenchymal phenotype …' [112] is open to dispute without the techniques to demonstrate it, and electron microscopy is one such technique.
Even when electron microscopy is performed, care is needed for appropriate interpretation. In a paper espousing EMT in the kidney [113] , figures have purported to show myofibroblasts as a final product of EMT, whereas the images arguably show either epithelium itself or endothelium [14, 15] [73, 115] . In addition to the lack of ultrastructural evidence of complete epithelial-to-myofibroblast transformation, there is inconsistent demonstration of a molecular marker for the myofibroblast, the ␣SMA gene [116, 117] 
